Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Biosimilars/Follow-on-Biologics Manufacturers Profiles, Market Size and Market Share 2019-report

Global Biosimilars/Follow-on-Biologics Manufacturers Profiles, Market Size and Market Share 2019

Report ID: 180696 3300 Pharma & Healthcare 377 242 Pages 4.9 (50)

A detailed study on Biosimilars/Follow-on-Biologics market complied by primary and secondary research and validated by industry experts. If you are planning to understand the Biosimilars/Follow-on-Biologics market in and out, then this is a must have report. You will also get free analyst support with this report.

Biosimilars/Follow-on-Biologics market is one of the markets, where investors have shown great interest. As per the research the market is expected to grow with a CAGR of XX% in coming years. Biosimilars/Follow-on-Biologics Market Sizes, Shares, Prices, Trends, and Forecasts have been derived from an in-depth study of the current scenarios in the. This report is based on both value and volume (Where applicable).

*This is a smart report which can be customized according to your need.

Highlights Of The Report:
1. Market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends.
3. Historical data and forecast.
4. Estimations for the forecast period between 2020 and 2026.
5. Developments and trends in the market.
6. By Type:
        Human growth hormone
        Monoclonal antibodies
7. By Application:
        Blood disorders
        Oncology diseases
        Chronic and autoimmune diseases
        Growth hormone deficiencies
8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

Overview of the regional outlook of the market:

  • The report offers information about the regions in the market, which is further divided into sub-regions and countries.
  • In addition to the market share of each country and sub-region, information regarding lucrative opportunities is included in this chapter of the report.
  • Share and market growth rate of each region, country, and sub-region are mentions in this chapter of the report during the estimated time period.

Companies profiled in this report:
      1) Novartis
      2) Synthon Pharmaceuticals
      3) Teva Pharmaceutical Industries
      4) LG Life Sciences
      5) Celltrion
      6) Biocon
      7) Hospira
      8) Merck Group
      9) Biogen idec, Inc.
      10) Genentech (Roche Group)12345

*Additional companies can be added in Biosimilars/Follow-on-Biologics market report as a part of free customization. Feel free to get in touch with our research analyst.

This chapter of the report comprises various key companies operating in the global market. This helps the reader understand the competitive landscape, including the strategies adopted by the players to stay in the competitive market.

  • Market Share
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Strategies

Reasons To Purchase The Biosimilars/Follow-on-Biologics Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
  • Moreover, we provide data support, in the excel format, and 1-year free analyst support.

Frequently Asked Questions?

Biosimilars are generic versions of biologic drugs, which are medications derived from living organisms. Follow-on biologics are similar to biosimilars, but they are products that have been modified after they were initially developed as biosimilars.

Some of the major companies in the biosimilars/follow-on-biologics market are Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group, Biogen idec, Inc..

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Biosimilars/Follow-on-Biologics Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Biosimilars/Follow-on-Biologics Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Biosimilars/Follow-on-Biologics Market - Supply Chain
   4.5. Global Biosimilars/Follow-on-Biologics Market Forecast
      4.5.1. Biosimilars/Follow-on-Biologics Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Biosimilars/Follow-on-Biologics Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Biosimilars/Follow-on-Biologics Market Absolute $ Opportunity

5. Global Biosimilars/Follow-on-Biologics Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      5.3.1. Human growth hormone
      5.3.2. Erythropoietin
      5.3.3. Monoclonal antibodies
      5.3.4. Insulin
      5.3.5. Interferon
      5.3.6. Granulocyte-Colony Stimulating Factor
      5.3.7. Peptide
      5.3.8. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Biosimilars/Follow-on-Biologics Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      6.3.1. Blood disorders
      6.3.2. Oncology diseases
      6.3.3. Chronic and autoimmune diseases
      6.3.4. Growth hormone deficiencies
      6.3.5. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Biosimilars/Follow-on-Biologics Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Biosimilars/Follow-on-Biologics Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Biosimilars/Follow-on-Biologics Demand Share Forecast, 2019-2026

9. North America Biosimilars/Follow-on-Biologics Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      9.4.1. Blood disorders
      9.4.2. Oncology diseases
      9.4.3. Chronic and autoimmune diseases
      9.4.4. Growth hormone deficiencies
      9.4.5. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      9.7.1. Human growth hormone
      9.7.2. Erythropoietin
      9.7.3. Monoclonal antibodies
      9.7.4. Insulin
      9.7.5. Interferon
      9.7.6. Granulocyte-Colony Stimulating Factor
      9.7.7. Peptide
      9.7.8. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Biosimilars/Follow-on-Biologics Demand Share Forecast, 2019-2026

10. Latin America Biosimilars/Follow-on-Biologics Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      10.4.1. Blood disorders
      10.4.2. Oncology diseases
      10.4.3. Chronic and autoimmune diseases
      10.4.4. Growth hormone deficiencies
      10.4.5. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      10.7.1. Human growth hormone
      10.7.2. Erythropoietin
      10.7.3. Monoclonal antibodies
      10.7.4. Insulin
      10.7.5. Interferon
      10.7.6. Granulocyte-Colony Stimulating Factor
      10.7.7. Peptide
      10.7.8. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Biosimilars/Follow-on-Biologics Demand Share Forecast, 2019-2026

11. Europe Biosimilars/Follow-on-Biologics Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      11.4.1. Blood disorders
      11.4.2. Oncology diseases
      11.4.3. Chronic and autoimmune diseases
      11.4.4. Growth hormone deficiencies
      11.4.5. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      11.7.1. Human growth hormone
      11.7.2. Erythropoietin
      11.7.3. Monoclonal antibodies
      11.7.4. Insulin
      11.7.5. Interferon
      11.7.6. Granulocyte-Colony Stimulating Factor
      11.7.7. Peptide
      11.7.8. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Biosimilars/Follow-on-Biologics Demand Share, 2019-2026

12. Asia Pacific Biosimilars/Follow-on-Biologics Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      12.4.1. Blood disorders
      12.4.2. Oncology diseases
      12.4.3. Chronic and autoimmune diseases
      12.4.4. Growth hormone deficiencies
      12.4.5. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      12.7.1. Human growth hormone
      12.7.2. Erythropoietin
      12.7.3. Monoclonal antibodies
      12.7.4. Insulin
      12.7.5. Interferon
      12.7.6. Granulocyte-Colony Stimulating Factor
      12.7.7. Peptide
      12.7.8. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Biosimilars/Follow-on-Biologics Demand Share, 2019-2026

13. Middle East & Africa Biosimilars/Follow-on-Biologics Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Application
      13.4.1. Blood disorders
      13.4.2. Oncology diseases
      13.4.3. Chronic and autoimmune diseases
      13.4.4. Growth hormone deficiencies
      13.4.5. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Biosimilars/Follow-on-Biologics Market Size and Volume Forecast by Type
      13.7.1. Human growth hormone
      13.7.2. Erythropoietin
      13.7.3. Monoclonal antibodies
      13.7.4. Insulin
      13.7.5. Interferon
      13.7.6. Granulocyte-Colony Stimulating Factor
      13.7.7. Peptide
      13.7.8. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Biosimilars/Follow-on-Biologics Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Biosimilars/Follow-on-Biologics Market: Market Share Analysis
   14.2. Biosimilars/Follow-on-Biologics Distributors and Customers
   14.3. Biosimilars/Follow-on-Biologics Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Novartis Overview Financials Developments Strategic Outlook
      14.4.2. Synthon Pharmaceuticals Overview Financials Developments Strategic Outlook
      14.4.3. Teva Pharmaceutical Industries Overview Financials Developments Strategic Outlook
      14.4.4. LG Life Sciences Overview Financials Developments Strategic Outlook
      14.4.5. Celltrion Overview Financials Developments Strategic Outlook
      14.4.6. Biocon Overview Financials Developments Strategic Outlook
      14.4.7. Hospira Overview Financials Developments Strategic Outlook
      14.4.8. Merck Group Overview Financials Developments Strategic Outlook
      14.4.9. Biogen idec, Inc. Overview Financials Developments Strategic Outlook
      14.4.10. Genentech (Roche Group) Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us